110 related articles for article (PubMed ID: 15334631)
1. Risk factors for peritoneal dissemination of colorectal cancer.
Yang SH; Lin JK; Lai CR; Chen CC; Li AF; Liang WY; Jiang JK
J Surg Oncol; 2004 Sep; 87(4):167-73. PubMed ID: 15334631
[TBL] [Abstract][Full Text] [Related]
2. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
Grotowski M; Maruszyński M; Piechota W
Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
[TBL] [Abstract][Full Text] [Related]
6. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
Sasaki A; Kawano K; Inomata M; Shibata K; Matsumoto T; Kitano S
Hepatogastroenterology; 2005; 52(66):1814-9. PubMed ID: 16334783
[TBL] [Abstract][Full Text] [Related]
7. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of positive cases with peritoneal lavage cytology in gastric cancer].
Yamamoto M; Mashino K; Shibahara K; Oki E; Kakeji Y; Baba H; Maehara Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1389-92. PubMed ID: 16227735
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of peritoneal cytology and the combination of peritoneal cytology and peritoneal dissemination in colorectal cancer.
Nishikawa T; Watanabe T; Sunami E; Tsuno NH; Kitayama J; Nagawa H
Dis Colon Rectum; 2009 Dec; 52(12):2016-21. PubMed ID: 19934924
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
12. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection.
Noura S; Ohue M; Seki Y; Yano M; Ishikawa O; Kameyama M
Dis Colon Rectum; 2009 Jul; 52(7):1312-20. PubMed ID: 19571710
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal cytology in colorectal cancer: incidence and prognostic value.
Gozalan U; Yasti AC; Yuksek YN; Reis E; Kama NA
Am J Surg; 2007 Jun; 193(6):672-5. PubMed ID: 17512274
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for peritoneal dissemination of gastric cancer.
Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
[TBL] [Abstract][Full Text] [Related]
16. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
Zhao XW; Jiang B; Han CZ; Jing JX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk factors for lymph node metastasis of colorectal cancer.
Takano S; Kato J; Yamamoto H; Shiode J; Nasu J; Kawamoto H; Okada H; Shiratori Y
Hepatogastroenterology; 2007; 54(75):746-50. PubMed ID: 17591053
[TBL] [Abstract][Full Text] [Related]
18. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
19. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic characteristics and postoperative prognosis in colorectal cancer with peritoneal dissemination].
Song W; He YL; Cai SR; Zhang CH; Chen CQ; Zhang XH
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1634-7. PubMed ID: 19094758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
